Oral Presentation Australian and New Zealand Society for Geriatric Medicine Annual Scientific Meeting 2026

Dementia prevalence in Aotearoa New Zealand: the IDEA project (#23)

Ngaire Kerse 1 , Xiaojing Sharon Wu 1 , Sarah Cullum 2 , Gary Cheung 2 , Rita Krishnamurthi 3 , Susan Yates 4 , Claudia Rivera 5 , Jackie Broadbent 6 , Lynette Tippett 4
  1. Department of General Practice and Primary Health Care, University of Auckland, Auckland, New Zealand
  2. Department of Psychological Medicine, University of Auckland, Auckland, New Zealand
  3. National Institute for Stroke and Applied Neurosciences, Auckland University of Technology, Auckland, New Zealand
  4. School of Psychology, University of Auckland, Auckland, New Zealand
  5. Department of Statistics, University of Auckland, Auckland, New Zealand
  6. Older Persons Health Service, Health NZ Te Whatu Ora Waitaha, Christchurch, Canterbury, New Zealand

Aims: Dementia cases in Aotearoa NZ are expected to triple over the next 30 years, yet accurate prevalence estimates remain limited. The IDEA project aims to determine dementia prevalence in Pākehā, Chinese, and Indian populations, enabling equity analyses with Māori and Pacific peoples.

 

Methods: A door‑knock survey is underway in randomly selected urban and rural meshblocks across two sites. Residents aged ≥65 years complete a doorstep cognitive screen administered by trained multilingual interviewers. A randomly selected subset receives full assessment using the 10/66 dementia protocol. Target sample sizes are 485 Pākehā, 410 Chinese, and 425 Indian/Fijian‑Indian participants (3% margin of error, 95% CI).

 

Results: In 20 months, >27,000 households were approached, 4,332 residents screened, and 1,653 completed full assessments; 31% declined interviews and 33.5% declined doorstep screening (updated results to mid‑2026 will be presented). Of 96 individuals meeting 10/66 criteria for dementia, 36 were aware of a diagnosis. Preliminary adjusted prevalence is 7.80% (95% CI: 5.92 - 9.69). When participants without an informant were included, with dementia status determined by clinical adjudication using available assessment data, adjusted prevalence was 10.17% (95% CI: 7.67–12.67). Prevalence increases sharply with age, from 4.6% at 65–74 years to 26% at ≥85 years.

 

Conclusions: The IDEA project provides the first robust, population‑specific dementia prevalence estimates for key ethnic groups in Aotearoa New Zealand. These data will support the design of culturally responsive dementia services.